Unconventional. Restless. Disruptive.
Clinical trial management reinvented
Elixia is a trusted clinical site organization, providing industry-leading patient recruitment and clinical trials management and analysis for Cardiology/Nephrology, Behavioral Health and Infectious Disease – not just for a single trial, but across your entire therapeutic pipeline.

Elixia Clinical Research:Services and Capabilities Brochure
Our breakthrough approach helps you meet milestones with speed and agility, and we enroll and retain the right patients, trial after trial.

Elixia Clinical Research:Services and Capabilities Brochure
Our breakthrough approach helps you meet milestones with speed and agility, and we enroll and retain the right patients, trial after trial.
Partnering across your portfolio to…
Access diverse patient populations
Improve public health outcomes
Speed new drugs to market faster
Reduce the need for costly clinical trials
Combating COVID-19 with AstraZeneca
Elixia-managed sites were responsible for representing a total of 47% of the enrolled minority population worldwide for monoclonal antibody therapy.

Extend access to advanced therapeutics throughout local communities
Elixia puts communities first through meaningful patient acquisition and education programs led by our Patient Outreach and Support Division.

Operations designed for rapid study startup
Concerted operations across five Elixia divisions allow for study startup through study activation timelines to see record efficiencies.

Meet database locks sooner
Elixia has consistently led the global enrollment efforts for its last 25 trials conducted.

Access diverse patient populations

Combating COVID-19 with AstraZeneca
Elixia-managed sites were responsible for representing a total of 47% of the enrolled minority population worldwide for monoclonal antibody therapy.
Improve public health outcomes

Extend access to advanced therapeutics throughout local communities
Elixia puts communities first through meaningful patient acquisition and education programs led by our Patient Outreach and Support Division.
Speed new drugs to market faster

Operations designed for rapid study startup
Concerted operations across five Elixia divisions allow for study startup through study activation timelines to see record efficiencies.
Reduce the need for costly clinical trials

Meet database locks sooner
Elixia has consistently led the global enrollment efforts for its last 25 trials conducted.
Reinvented processes for repeated successes
STUDY STARTUP AND REGULATORY SUBMISSION
3-4 Days
FIRST RANDOMIZED PATIENT POST SITE ACTIVATION
1 – 2 Days
INTERNALLY DIRECTED SITE AUDIT
Within 10 Days
50% OF INITIAL ENROLLMENT GOAL, ON AVERAGE
12-16 Weeks
HOW WE DO IT
TECHNOLOGY
Expedite trials with our ElixiaXscientia advanced technology platform.


Rapid Patient Enrollment
Manage real-time study enrollment progress across every trial in the network

Focus on Diversity and Inclusion
Ensure patient enrollment reflects the diversity of real-world populations

UNCOMMON THERAPEUTIC EXPERTISE
Our extensive national network represents deep therapeutic expertise in highly specialized areas

Cardio-Renal Network
30+ years of experience combined with the largest one-of-a-kind cardio-renal network in the US

Behavioral Health
The only initiative focused on 100% inclusive behavioral health trials through a team of top clinical psychologists.

Infectious Disease
An agile footprint in infectious disease trials, proven through record-setting study startup and enrollment metrics throughout COVID-19.
REFINED MANAGEMENT PROCESSES
We eliminate traditional trial bottlenecks with a singular combination of specialized clinical expertise and an agile operating model with reproducible processes to deliver unprecedented results.


Reproducible Excellence
Built-in collaboration and operational efficiencies for streamlined, strategic execution and responsive agility

Curiosity and Perspective
An agile, passionate team of seasoned industry leaders dedicated to reinventing the way trials are conducted
Disrupting the one-and-done paradigm with pipeline strategies for your success from early phase through commercialization

Comprehensive, elite site management and clinical trials services. Preferred partnerships and alliances with more than 37 pharmaceutical companies and CROs.


World-class proprietary ElixiaXscientia data platform and innovative operational workflows drive patient recruitment, clinical trials management and post-market data collection and analysis.



Our ready patient and physician network extends access to advanced therapeutics throughout local communities, giving you a more robust picture of safety and efficacy


